Hansong Sun

Hansong Sun

Auto-generated profile, based on publicly available information

Hansong Sun

Department of Cardiovascular Surgery Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2019 in Journal of Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Closed access
HXHaitao Xu
Haitao Xu
YDYabing Duan
Yabing Duan
XYXin Yuan
Xin Yuan
HWHengchao Wu
Hengchao Wu
HSHansong Sun
Hansong Sun
HJHongwen Ji
Hongwen Ji

16 December 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TYTao Yang
Tao Yang
MLMinjie Lu
Minjie Lu
HSHan-Song Sun
Han-Song Sun
YTYue Tang
Yue Tang
SPShi-Wei Pan
Shi-Wei Pan
SZShihua Zhao
Shihua Zhao
Previous studies have shown that viable myocardium predicts recovery of left ventricular (LV) dysfunction after revascularization. Our aim was to evaluate the prognostic value of myocardial scar assessed by late gadolinium-enhanced cardiovascular magnetic resonance imaging (LGE-CMR) on functional recovery in patients undergoing coronary artery bypass grafting (CABG). From November 2009 to September 2012, 63 patients with reduced left ventricular ejection fraction (LVEF) referred for first-time isolated CABG were prospectively enrolled, 52 were included in final analysis. LV functional parameters and scar tissue were assessed by LGE-CMR at baseline and 6 months after surgery. Patency of grafts was evaluated by computed tomography angiography (CTA) 6 months post-CABG. Predictors for global functional recovery were analyzed. The baseline LVEF was 32.7±9.2%, which improved to 41.6±11.0% 6 months later and 32/52 patients improved LVEF by ≥5%. Multivariate logistic regression analysis showed that the most significant negative predictor for global functional recovery was the number of scar segments (Odds ratio 2.864, 95% Confidence Interval 1.172–6.996, p = 0.021). Receiver-Operator-Characteristic (ROC) analysis demonstrated that ≤4 scar segments predicted global functional recovery with a sensitivity and specificity of 85.0% and 87.5%, respectively (AUC = 0.91, p<0.001). Comparison of ROC curves also indicated that scar tissue was superior to viable myocardium in predicting cardiac functional recovery (p<0.001). Our findings indicated that scar tissue on LGE-CMR is an independent negative predictor of cardiac functional recovery in patients with impaired LV function undergoing CABG. These observations may be helpful for clinicians and cardiovascular surgeons to determine which patients are most likely to benefit from surgical revascularization.

23 February 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
FXFucheng Xiao
Fucheng Xiao
HWHengchao Wu
Hengchao Wu
HSHansong Sun
Hansong Sun
SPShiwei Pan
Shiwei Pan
JXJianping Xu
Jianping Xu
YSYunhu Song
Yunhu Song
To date, effect of preoperatively continued aspirin administration in off-pump coronary artery bypass grafting (CABG) is less known. We aimed to assess the effect of preoperatively continued aspirin use on early and mid-term outcomes in patients receiving off-pump CABG. From October 2009 to September 2013 at the Fuwai Hospital, 709 preoperative aspirin users were matched with unique 709 nonaspirin users using propensity score matching to obtain risk-adjusted outcome comparisons between the two groups. Early outcomes were in-hospital death, stroke, intra- and post-operative blood loss, reoperation for bleeding and blood product transfusion. Major adverse cardiac events (death, myocardial infarction or repeat revascularization), angina recurrence and cardiogenic readmission were considered as mid-term endpoints. There were no significant differences among the groups in baseline characteristics after propensity score matching. The median intraoperative blood loss (600 ml versus 450 ml, P = 0.56), median postoperative blood loss (800 ml versus 790 ml, P = 0.60), blood transfusion requirements (25.1% versus 24.4%, P = 0.76) and composite outcome of in-hospital death, stroke and reoperation for bleeding (2.8% versus 1.6%, P = 0.10) were similar in aspirin and nonaspirin use group. At about 4 years follow-up, no significant difference was observed among the aspirin and nonaspirin use group in major adverse cardiac events free survival estimates (95.7% versus 91.5%, P = 0.23) and freedom from cardiogenic readmission (88.5% versus 85.3%, P = 0.77) whereas the angina recurrence free survival rates was 83.7% and 73.9% in the aspirin and nonaspirin use group respectively (P = 0.02), with odd ratio for preoperative aspirin estimated at 0.71 (95% confidence interval, 0.49-1.04, P = 0.08). Preoperatively continued aspirin use was not associated with increased risk of intra- and post-operative blood loss, blood transfusion requirements and composite outcome of in-hospital death, stroke and reoperation for bleeding in off-pump CABG. Preoperative aspirin use tended to decrease the hazard of mid-term angina recurrence.

24 January 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
BLBaotong Li
Baotong Li
SCShanglin Chen
Shanglin Chen
HSHansong Sun
Hansong Sun
JXJianping Xu
Jianping Xu
YSYunhu Song
Yunhu Song
SWShuiyun Wang
Shuiyun Wang
Although practice guidelines recommend surgery for patients with severe chronic ischemic mitral regurgitation (CIMR), they do not specify whether to repair or replace the mitral valve. 436 consecutive patients with severe CIMR were eligible for inclusion in the study, of which 316 (72.5%) underwent mitral valve annuloplasty (MVA) whereas 120 (27.5%) received mitral valve replacement (MVR). At 59 months (interquartile range, 37–85 months) follow-up, though the left ventricle end-diastolic diameter was markedly larger (P = 0.019) in the MVA group than in the MVR group, no significant difference was observed in overall survival, freedom from cardiac death, or avoidance of major adverse cardiac or cerebrovascular events (MACCE). MVA provides better results in freedom from cardiac death in subgroups of age ≥65years and left ventricular ejection fraction (EF) ≥50% (P = 0.014 and P = 0.016, respectively), whereas MVR was associated with a lower risk of MACCE in subgroups of age <65years, EF <50% and left ventricular inferior basal wall motion abnormality (BWMA) (all P < 0.05). In conclusion, MVR is a suitable management of patients with severe CIMR, and it is more favorable to ventricular remodeling. The choice of MVA or MVR should depend on major high-risk clinical factors.

13 July 2023 in Hypertension Research
Verified
Journal Article
Closed access
PDF file
TYTao Yang
Tao Yang
XYXin Yuan
Xin Yuan
WGWei Gao
Wei Gao
MLMinjie Lu
Minjie Lu
MHMeng-Jin Hu
Meng-Jin Hu
HSHan-Song Sun
Han-Song Sun

31 August 2020 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
KYKai Yang
Kai Yang
XLXiaokang Luo
Xiaokang Luo
YTYue Tang
Yue Tang
HHHaibo Hu
Haibo Hu
HSHansong Sun
Hansong Sun